Polyclonal Antibody to Breast Cancer Susceptibility Protein 2 (BRCA2)
Ref: CC-PAB364Mu02-200 ul
BRCA2; BRCC2; FACD; FAD; FAD1; FANCD; FANCD1; Breast Cancer 2,Early Onset; Breast Cancer Type 2 Susceptibility Protein; Fanconi anemia group D1 protein
Información del producto
Información adicional
Size
200 ul
Applications
WB
Research Area
Tumor immunity
Immunogen
RPB364Mu02-Recombinant Breast Cancer Susceptibility Protein 2 (BRCA2)
Organism species
Mus musculus (Mouse)
Alternative Names
BRCA2
Item Name
Breast Cancer Susceptibility Protein 2
Host
Rabbit
UniProt ID
P97929
Buffer Formulation
0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Usage
Western blotting: 0.5-2µg/mL
Immunohistochemistry: 5-20µg/mL
Immunocytochemistry: 5-20µg/mL
Optimal working dilutions must be determined by end user.
Immunohistochemistry: 5-20µg/mL
Immunocytochemistry: 5-20µg/mL
Optimal working dilutions must be determined by end user.
Tissue Source
Polyclonal antibody preparation